Literature DB >> 21787843

Functional reorganization of the presynaptic dopaminergic terminal in parkinsonism.

B P Bergstrom1, S G Sanberg, M Andersson, J Mithyantha, F I Carroll, P A Garris.   

Abstract

Whether dopamine (DA) release is compensated during the presymptomatic phase of Parkinson's disease (PD) is controversial. Here we use in vivo voltammetry in the parkinsonian rat and an electrical stimulation protocol established to fatigue nigrostriatal dopaminergic (DAergic) neurons to investigate the plasticity of DA-release mechanisms. Amplitudes of evoked voltammetric signals recorded in intact rat striata decreased with repetitive, high-frequency stimulation (60 Hz, every 5 min/60 min). Strikingly, DA levels were maintained during an identical "fatiguing" protocol in 6-hydroxydopamine-lesioned (<40% denervation) striata in the absence of enhanced DA synthesis. In contrast, more severely lesioned striata (>55% denervation) also appeared to sustain DA release, however, this was demonstrated in the presence of enhanced synthesis. Sustained release was replicated in intact animals after irreversible blockade of the dopamine transporter (DAT) via RTI-76, implicating neuronal uptake as a trigger. We further demonstrate through kinetic analysis that lesions and compromised uptake target a "long-term" (time constant of minutes) presynaptic depression, which underlies the maintenance of release. Taken together, our findings identify a denervation-induced maintenance of DA release that was independent of activated synthesis and driven by altered uptake. This novel neuroadaptation may contribute to early preclinical normalization of function and help resolve discrepant findings regarding compensatory changes in DA release during progression of the parkinsonian state.
Copyright © 2011 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21787843      PMCID: PMC3171576          DOI: 10.1016/j.neuroscience.2011.07.029

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  53 in total

Review 1.  Gating of information flow within the limbic system and the pathophysiology of schizophrenia.

Authors:  A A Grace
Journal:  Brain Res Brain Res Rev       Date:  2000-03

2.  Utility of a tripolar stimulating electrode for eliciting dopamine release in the rat striatum.

Authors:  B P Bergstrom; P A Garris
Journal:  J Neurosci Methods       Date:  1999-03-01       Impact factor: 2.390

3.  Preferential increases in nucleus accumbens dopamine after systemic cocaine administration are caused by unique characteristics of dopamine neurotransmission.

Authors:  Q Wu; M E Reith; M J Kuhar; F I Carroll; P A Garris
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

4.  Synaptic vesicle pools at the frog neuromuscular junction.

Authors:  David A Richards; Cristina Guatimosim; Silvio O Rizzoli; William J Betz
Journal:  Neuron       Date:  2003-07-31       Impact factor: 17.173

5.  Determination of release and uptake parameters from electrically evoked dopamine dynamics measured by real-time voltammetry.

Authors:  Q Wu; M E Reith; R M Wightman; K T Kawagoe; P A Garris
Journal:  J Neurosci Methods       Date:  2001-12-15       Impact factor: 2.390

6.  Time window of autoreceptor-mediated inhibition of limbic and striatal dopamine release.

Authors:  Paul E M Phillips; Pamela J Hancock; Jonathan A Stamford
Journal:  Synapse       Date:  2002-04       Impact factor: 2.562

7.  Partial, graded losses of dopamine terminals in the rat caudate-putamen: an animal model for the study of compensatory adaptation in preclinical parkinsonism.

Authors:  B P Bergstrom; K E Schertz; T Weirick; B Nafziger; S A Takacs; K O Lopes; K J Massa; Q D Walker; P A Garris
Journal:  J Neurosci Methods       Date:  2001-03-30       Impact factor: 2.390

8.  Adaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse.

Authors:  E Bezard; M Jaber; F Gonon; A Boireau; B Bloch; C E Gross
Journal:  Eur J Neurosci       Date:  2000-08       Impact factor: 3.386

9.  Functional heterogeneity at dopamine release sites.

Authors:  James A Daniel; Sally Galbraith; Lorraine Iacovitti; Andrea Abdipranoto; Bryce Vissel
Journal:  J Neurosci       Date:  2009-11-18       Impact factor: 6.167

10.  Variable dopamine release probability and short-term plasticity between functional domains of the primate striatum.

Authors:  Stephanie J Cragg
Journal:  J Neurosci       Date:  2003-05-15       Impact factor: 6.167

View more
  12 in total

Review 1.  Electrochemical Analysis of Neurotransmitters.

Authors:  Elizabeth S Bucher; R Mark Wightman
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2015-05-04       Impact factor: 10.745

2.  Methamphetamine-induced neurotoxicity disrupts pharmacologically evoked dopamine transients in the dorsomedial and dorsolateral striatum.

Authors:  John D Robinson; Christopher D Howard; Elissa D Pastuzyn; Diane L Byers; Kristen A Keefe; Paul A Garris
Journal:  Neurotox Res       Date:  2014-02-22       Impact factor: 3.911

3.  MPTP Mouse Model of Preclinical and Clinical Parkinson's Disease as an Instrument for Translational Medicine.

Authors:  Eduard R Mingazov; Gulnara R Khakimova; Elena A Kozina; Alexei E Medvedev; Olga A Buneeva; Ara S Bazyan; Michael V Ugrumov
Journal:  Mol Neurobiol       Date:  2017-04-29       Impact factor: 5.590

Review 4.  Applying a Fast-Scan Cyclic Voltammetry to Explore Dopamine Dynamics in Animal Models of Neuropsychiatric Disorders.

Authors:  Vladimir P Grinevich; Amir N Zakirov; Uliana V Berseneva; Elena V Gerasimova; Raul R Gainetdinov; Evgeny A Budygin
Journal:  Cells       Date:  2022-05-03       Impact factor: 7.666

5.  The spontaneously hypertensive and Wistar Kyoto rat models of ADHD exhibit sub-regional differences in dopamine release and uptake in the striatum and nucleus accumbens.

Authors:  Erin M Miller; Francois Pomerleau; Peter Huettl; Vivienne A Russell; Greg A Gerhardt; Paul E A Glaser
Journal:  Neuropharmacology       Date:  2012-09-01       Impact factor: 5.250

6.  Regulation of Tyrosine Hydroxylase Expression and Phosphorylation in Dopamine Transporter-Deficient Mice.

Authors:  Michael F Salvatore; Erin S Calipari; Sara R Jones
Journal:  ACS Chem Neurosci       Date:  2016-05-10       Impact factor: 4.418

7.  Loss of Homeostasis in the Direct Pathway in a Mouse Model of Asymptomatic Parkinson's Disease.

Authors:  Mariela V Escande; Irene R E Taravini; Camila L Zold; Juan E Belforte; M Gustavo Murer
Journal:  J Neurosci       Date:  2016-05-25       Impact factor: 6.167

8.  Methamphetamine-induced neurotoxicity disrupts naturally occurring phasic dopamine signaling.

Authors:  Christopher D Howard; David P Daberkow; Eric S Ramsson; Kristen A Keefe; Paul A Garris
Journal:  Eur J Neurosci       Date:  2013-04-11       Impact factor: 3.386

9.  Dopamine transporter loss in 6-OHDA Parkinson's model is unmet by parallel reduction in dopamine uptake.

Authors:  Tanya Chotibut; Deana M Apple; Rebecca Jefferis; Michael F Salvatore
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

10.  Using in vivo voltammetry to demonstrate drug action: a student laboratory experience in neurochemistry.

Authors:  Brian P Bergstrom
Journal:  J Undergrad Neurosci Educ       Date:  2012-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.